Square Pharma experienced a 33.61 percent year-on-year rise in profits in the October-December period last year on the back of higher operating efficiency.
Revenue growth and lower cost of sales also accounted for the profit of Tk 159 crore during the quarter. The medicine manufacturer saw revenue growth of 13.4 percent, while cost of sales went down to 51.1 percent.
The earnings per share stood at Tk 3.30 during the quarter in contrast to Tk 2.48 a year ago. The price earnings ratio of the company stood at 20.88 until yesterday.
Amongst the top ten stocks by market capitalisation, the company's net profit after tax rose 26.5 percent year-on-year to Tk 410 crore in the nine months to December.
The company's shares traded at Tk 237 yesterday, with some 6.16 lakh shares worth Tk 14 crore exchanged on the trading floor.